Equities researchers at Piper Jaffray Companies initiated coverage on shares of Envision Healthcare (NYSE:EVHC) in a report released on Wednesday, MarketBeat reports. The firm set a “neutral” rating and a $35.00 price target on the stock. Piper Jaffray Companies’ price target points to a potential upside of 4.88% from the company’s previous close.
EVHC has been the topic of a number of other research reports. Citigroup lowered Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 price objective on the stock. in a research note on Thursday, November 2nd. BidaskClub downgraded Envision Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 17th. Bank of America reduced their target price on Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, October 9th. Canaccord Genuity restated a “buy” rating and issued a $32.00 target price (down previously from $68.00) on shares of Envision Healthcare in a research report on Thursday, November 2nd. Finally, KeyCorp reduced their target price on Envision Healthcare from $67.00 to $37.00 and set an “overweight” rating on the stock in a research report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Envision Healthcare currently has an average rating of “Buy” and an average target price of $46.06.
Envision Healthcare (NYSE EVHC) traded down $0.03 during midday trading on Wednesday, reaching $33.37. The company’s stock had a trading volume of 4,039,479 shares, compared to its average volume of 2,267,143. The firm has a market capitalization of $3,977.26, a price-to-earnings ratio of 10.15, a P/E/G ratio of 0.85 and a beta of 0.57. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare has a one year low of $23.77 and a one year high of $73.00.
Envision Healthcare announced that its board has initiated a stock buyback plan on Monday, September 18th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 4.5% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.
Hedge funds have recently bought and sold shares of the stock. Exane Derivatives purchased a new stake in shares of Envision Healthcare in the 3rd quarter valued at $475,000. Stonebridge Capital Management Inc. raised its holdings in shares of Envision Healthcare by 87.0% in the 3rd quarter. Stonebridge Capital Management Inc. now owns 30,329 shares of the company’s stock valued at $1,364,000 after buying an additional 14,111 shares during the period. Honeywell International Inc. raised its holdings in shares of Envision Healthcare by 17.4% in the 3rd quarter. Honeywell International Inc. now owns 542,100 shares of the company’s stock valued at $24,367,000 after buying an additional 80,200 shares during the period. Schwab Charles Investment Management Inc. raised its holdings in shares of Envision Healthcare by 5.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 632,195 shares of the company’s stock valued at $39,620,000 after buying an additional 33,587 shares during the period. Finally, Nomura Holdings Inc. purchased a new stake in shares of Envision Healthcare in the 2nd quarter valued at $797,000.
COPYRIGHT VIOLATION WARNING: “Envision Healthcare (EVHC) Coverage Initiated by Analysts at Piper Jaffray Companies” was first posted by American Banking and Market News and is the property of of American Banking and Market News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/12/13/envision-healthcare-evhc-coverage-initiated-by-analysts-at-piper-jaffray-companies.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
